TrialThe Pediatric infectious disease journal2020

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia.

Emmanuel Roilides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.